# Syner-G BioPharma Group

confirmed via five separate published case studies on its own domain, covering CDMO-to-in-house cGMP manufacturing scale-up in cell therapy, end-to-end CMC enablement for a clinical-stage biotech, smart scale-up solutions, technology-transfer mobilization to a CDMO,…

Source: https://en.bioecon.ru/companies/syner-g-biopharma/
Updated: 2026-08-21

- Country: United States

## Technologies

- [Bioprocess scale-up consulting](https://en.bioecon.ru/technology/bioprocess-scale-up-consulting/)